SuperworthAtea Pharmaceuticals shares outstanding AVIR
Diluted shares outstanding, averaged over each quarter, from 2019.
- Latest quarter, to Jun 30, 2026
- 80.1M
- On a year earlier
- −4.4%
- fewer shares
Atea Pharmaceuticals had 80.1M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 4.4% fewer than a year earlier, so each share owns a little more of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 78.1M | −7% |
| FY2024 | 84.5M | +1% |
| FY2023 | 83.4M | +0% |
| FY2022 | 83.3M | −5% |
| FY2021 | 87.6M | +57% |
| FY2020 | 55.8M | +453% |
| FY2019 | 10.1M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 80.1M | −4% | |
| Q1 FY26 | 79.2M | −7% | |
| Q4 FY25 | 78.1M | −7% | |
| Q3 FY25 | 79.1M | −6% | |
| Q2 FY25 | 83.7M | −1% | |
| Q1 FY25 | 85.2M | +1% | |
| Q4 FY24 | 84.5M | +1% | |
| Q3 FY24 | 84.4M | +1% | |
| Q2 FY24 | 84.3M | +1% | |
| Q1 FY24 | 83.9M | +1% | |
| Q4 FY23 | 83.4M | +0% | |
| Q3 FY23 | 83.4M | +0% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Atea Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.